Complementary medicines are widely used and often perceived as safe, yet high doses, product stacking, and unclear labelling can quietly increase the risk of harm.

07 April 2026

An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.

30 March 2026

While underreporting remains a persistent global challenge, innovative approaches are showing promise in different regions

18 February 2026

Online psychedelic forums hold untapped safety data. AI analysis of user narratives could help pharmacovigilance systems detect risks missed by traditional reporting.

13 November 2025